ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07379
0,19%
Bitcoin
66.531,88
-0,16%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) News

ARWR Arrowhead Pharmaceuticals Inc

25,10
-0,74 (-2,86%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:41:08
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,74 -2,86% 25,10 23:41:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
25,71 24,51 25,76 25,10 25,84
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.5.202422:11EDGAR2Form 8-K - Current report
07.5.202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.4.202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
08.3.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:30EDGAR2Form 144 - Report of proposed sale of securities
27.2.202423:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06.2.202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.2.202422:07EDGAR2Form 8-K - Current report
02.2.202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:57EDGAR2Form 144 - Report of proposed sale of securities
26.1.202423:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202423:22EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:16EDGAR2Form 144 - Report of proposed sale of securities
11.1.202422:48EDGAR2Form 144 - Report of proposed sale of securities
11.1.202422:38EDGAR2Form 144 - Report of proposed sale of securities
11.1.202422:22EDGAR2Form 144 - Report of proposed sale of securities
11.1.202422:05EDGAR2Form 144 - Report of proposed sale of securities
08.1.202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.1.202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.1.202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202423:33EDGAR2Form 144 - Report of proposed sale of securities
05.1.202423:14EDGAR2Form 144 - Report of proposed sale of securities
05.1.202422:58EDGAR2Form 144 - Report of proposed sale of securities
05.1.202422:39EDGAR2Form 144 - Report of proposed sale of securities
05.1.202422:21EDGAR2Form 144 - Report of proposed sale of securities
05.1.202422:08EDGAR2Form 144 - Report of proposed sale of securities
04.1.202423:27EDGAR2Form 8-K - Current report
04.1.202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04.1.202419:49EDGAR2Form 144 - Report of proposed sale of securities
04.1.202419:25EDGAR2Form 144 - Report of proposed sale of securities
04.1.202419:06EDGAR2Form 144 - Report of proposed sale of securities
04.1.202418:24EDGAR2Form 144 - Report of proposed sale of securities
02.1.202422:44EDGAR2Form 144 - Report of proposed sale of securities
22.12.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:34EDGAR2Form 144 - Report of proposed sale of securities
19.12.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202321:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:16EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
ARWR
Arrowhead Pharmaceuticals
BIT
P1MLP1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten